Kamada(KMDA) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Kamada Declares $0.20 Dividend
Seeking AlphaMar 24 08:02 ET
Express News | Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
ReutersMar 24 07:00 ET
Press Release: Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
Dow JonesMar 24 07:00 ET
Benchmark Co. Initiates Kamada(KMDA.US) With Buy Rating, Announces Target Price $15
Moomoo NewsMar 22 02:32 ET · Ratings
Kamada Initiated at Buy by Benchmark
Dow JonesMar 21 09:53 ET · Ratings
Benchmark Initiates Kamada at Buy With $15 Price Target
MT NewswiresMar 21 07:23 ET · Ratings

Comments

Tonyco

Mar 7 08:40

$Kamada (KMDA.US)$

Teddy123

Mar 5 20:10

Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth

$Kamada (KMDA.US)$
Kamada Delivers 75% Profit Growth in 2024 - Is This Biotech Stock Ready for a Breakout?

EC2025

Feb 26 02:44

$Kamada (KMDA.US)$ Recent Developments: 🚀🚀🚀🚀👀
• Financial Guidance for 2025: On January 8, 2025, Kamada affirmed its 2024 financial guidance, expecting revenues between $158 million and $162 million, and adjusted EBITDA between $32 million and $35 million. For 2025, the company forecasts revenues between $178 million and $182 million, and adjusted EBITDA between $38 million and $42 million, representing a 13% increase in revenues and a 19% increase in adjusted EBITDA based on the mid-point of ...

Jaguar8

Jan 23 13:28

🟤 Watchlist, JANUARY 23,2025, Thursday. NFA

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards t...

61

17

9

Jaguar8

Jan 22 20:06

NEWS

$Kamada (KMDA.US)$
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
Kamada (NASDAQ: KMDA) has secured a significant $25 million contract for supplying KAMRAB® and VARIZIG® in Latin America over a three-year period from 2025-2027. This contract with an international organization reinforces Kamada's position in the specialty plasma-derived field.
KAMRAB is used for post-exposure prevention of rabies infection, while VARIZIG is indicated for pos...

1

KMDA Kamada

Trade Overview

Capital Trend

News

Comments

Market Insights